FDA Media Alert Detail

Drug Shortage

FDA Drug Shortage: Mesalamine Capsule, Extended Release

  • U.S. Food and Drug Administration
  • August 25, 2026
  • ID: shortage-mesalamine-capsule-extended-release-mylan-pharmaceuticals-inc-a-viatris-company-0378-1375-78

Drug Shortage Details

Generic NameMesalamine Capsule, Extended Release
Manufacturer / CompanyMylan Pharmaceuticals Inc., a Viatris Company
Therapeutic CategoryGastroenterology
Availability StatusShortage
Status (FDA list)To Be Discontinued
NDC Package Code0378-1375-78
Presentation & Dosage Form

Mesalamine, Capsule, Extended Release, .375 g (NDC 0378-1375-78)

Manufacturer Contact Info

800-796-9526


Content syndicated from the U.S. Food and Drug Administration (FDA) Drug Shortages Database.